Medidata Solutions Stock Price, News & Analysis (NASDAQ:MDSO)

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

Medidata Solutions Inc (NASDAQ:MDSO) posted its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.31. The company earned $180.50 million during the quarter, compared to analysts' expectations of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. Medidata Solutions's revenue for the quarter was up 15.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.43 earnings per share. View Medidata Solutions' Earnings History.

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Medidata Solutions.

8 equities research analysts have issued twelve-month price objectives for Medidata Solutions' shares. Their predictions range from $70.00 to $96.00. On average, they expect Medidata Solutions' stock price to reach $85.91 in the next year. This suggests that the stock has a possible downside of 6.4%. View Analyst Price Targets for Medidata Solutions.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Media headlines about MDSO stock have trended negative this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medidata Solutions earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Medidata Solutions.

Some companies that are related to Medidata Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Allscripts Healthcare Solutions (MDRX), HealthStream (HSTM), Vocera Communications (VCRA), Cortexyme (CRTX), Computer Programs & Systems (CPSI) and Greenway Health (GWAY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), Gilead Sciences (GILD), Allergan (AGN), salesforce.com (CRM), IBM (IBM), Alphabet (GOOG), Intel (INTC), Ionis Pharmaceuticals (IONS) and Western Digital (WDC).

Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional investors include Syquant Capital Sas (2.48%), Assenagon Asset Management S.A. (0.88%), Candriam Luxembourg S.C.A. (0.50%), Havens Advisors LLC (0.08%), Whittier Trust Co. (0.04%) and Arcadia Investment Management Corp MI (0.04%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

MDSO stock was sold by a variety of institutional investors in the last quarter, including Arcadia Investment Management Corp MI, Envestnet Asset Management Inc., Pacer Advisors Inc. and State of Michigan Retirement System. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

MDSO stock was bought by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Assenagon Asset Management S.A., Candriam Luxembourg S.C.A., Havens Advisors LLC, State of Alaska Department of Revenue, Cerebellum GP LLC, Nisa Investment Advisors LLC and Whittier Trust Co. of Nevada Inc.. View Insider Buying and Selling for Medidata Solutions.

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDSO stock can currently be purchased for approximately $91.75.

Medidata Solutions has a market capitalization of $5.73 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

The official website for Medidata Solutions is http://www.mdsol.com/.

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]